Cell/virus bank is your starting material for your biologics manufacturing process. Extensive characterization at this stage is important to ensure viral safety and genetic stability.
We leverage decades of experience in testing at every phase from pre-clinical through commercialization to deliver comprehensive testing and expert regulatory guidance.
We partner with you to perform a risk assessment to determine the factors that may influence the potential level of infectious particles to effectively characterize the cell line.
To continue reading please sign in or create an account.Don't Have An Account?